APA (7th ed.) Citation

M, A. A., ZLM, H., M, M., A, L., CE, H., AC, K., . . . H, R. (2022). Recombinant human C1 esterase inhibitor as prophylactic treatment in idiopathic non-histaminergic angioedema. Allergy, 77(12), 3673. https://doi.org/10.1111/all.15437

Chicago Style (17th ed.) Citation

M, Alizadeh Aghdam, Hofman ZLM, Meertens M, Lebens A, Hack CE, Knulst AC, Maas C, and Röckmann H. "Recombinant Human C1 Esterase Inhibitor as Prophylactic Treatment in Idiopathic Non-histaminergic Angioedema." Allergy 77, no. 12 (2022): 3673. https://doi.org/10.1111/all.15437.

MLA (9th ed.) Citation

M, Alizadeh Aghdam, et al. "Recombinant Human C1 Esterase Inhibitor as Prophylactic Treatment in Idiopathic Non-histaminergic Angioedema." Allergy, vol. 77, no. 12, 2022, p. 3673, https://doi.org/10.1111/all.15437.